Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Acute Coronary Syndrome; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; ST Elevation Myocardial Infarction; Treatment Outcome; Comparative Study (1)
- Anticoagulants -- therapeutic use; Atrial Fibrillation -- therapy; Factor Xa Inhibitors -- therapeutic use; Hemorrhage -- chemically induced; Warfarin -- therapeutic use (1)
- Atherosclerosis -- drug therapy; Complementary Therapies; Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use; Hyperlipidemias -- drug therapy; Treatment Adherence and Compliance; Comparative Study (1)
Articles 1 - 3 of 3
Full-Text Articles in Cardiovascular Diseases
Acute Myocardial Infarction: Are We Overlooking Nstemi?, Kevin D. Swenson
Acute Myocardial Infarction: Are We Overlooking Nstemi?, Kevin D. Swenson
Physician Assistant Scholarly Project Posters
• Acute myocardial infarction (AMI) is one of the leading causes of death in the United States.
• The purpose of this study was to examine methods of clinical differentiation between ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) and then to compare the various treatment methods and subsequent outcomes in STEMI versus NSTEMI.
• A compilation of systematic reviews, medical journals, practice guidelines, medical texts and meta-analyses were researched for the purpose of this study.
• NSTEMI patients are older, have more comorbidities and present with more atypical symptoms than STEMI patients.
• NSTEMI patients are treated less aggressively …
Alternative Treatment With Red Yeast Rice To Reduce Hyperlipidemia, Lisa Froemke
Alternative Treatment With Red Yeast Rice To Reduce Hyperlipidemia, Lisa Froemke
Physician Assistant Scholarly Project Posters
• First line treatment of cardiovascular disease is lifestyle modification followed by the pharmacologic intervention of HMG-CoA reductase inhibitors or statins
• Statins are commonly associated with intolerable side effects such as myalgia leading to medication non-compliance
• RYR preparations claim to inhibit cholesterol synthesis without causing myalgia
• RYR preparations have naturally occurring monacolins such as monacolin K which is chemically identical to lovastatin
• RYR is not regulated by the FDA leading to questionable manufacturing practices producing varying ingredient composition
• The purpose of this study is to investigate the role RYR in hyperlipidemia treatment compared to statins …
New Age Anticoagulants: A Safer And More Effective Alternative To Warfarin?, Benjamin Johnson
New Age Anticoagulants: A Safer And More Effective Alternative To Warfarin?, Benjamin Johnson
Physician Assistant Scholarly Project Posters
Atrial fibrillation is the most common sustained heart rhythm in the United States with estimated prevalence rates of 8.8/100 (Wolf, Abbott, & Kannel, 1991). The largest risk for patients with atrial fibrillation is that of ischemic stroke from embolization of an atrial clot, thus the long standing treatment for this arrhythmia is aggressive anticoagulation. For decades this has been accomplished with the use of warfarin, however, the increased risk of hemorrhage combined with the inconvenience of weekly blood testing has prompted the development of potentially safer and more effective alternatives. A systematic review of the literature identified studies that examined …